navify Mutation Profiler*

Empowering next-generation sequencing clinical and research labs with actionable information

The emergence of next-generation sequencing (NGS) has played a major role in the shift toward precision medicine. But the amount of patient-specific data that NGS generates and the ever-growing body of knowledge that must be interpreted have proven to be as much of a challenge for healthcare facilities as an opportunity.

navify Mutation Profiler*

Empowering next-generation sequencing clinical and research labs with actionable information

The emergence of next-generation sequencing (NGS) has played a major role in the shift toward precision medicine. But the amount of patient-specific data that NGS generates and the ever-growing body of knowledge that must be interpreted have proven to be as much of a challenge for healthcare facilities as an opportunity.

navify Mutation Profiler is a clinical NGS reporting solution

navify Mutation Profiler can help labs accurately and efficiently interpret the clinical significance of mutations, empowering clinicians to deliver more personalized healthcare. It has been shown to reduce the time needed to draft a curation report by 75%*, and increases reproducibility while automating the workflow of report generation¹. With navify Mutation Profiler, labs are enabled to inform on potential personalized treatment strategies in a concise, professional report for the oncologist.

navify Mutation Profiler offers:

  • Clear presentation of mutations and potential treatment options
  • Simpler, more concise reports
  • Clinical significance for thousands of the most common variants classified in accordance with Association for Molecular Pathology guidelines
  • Public annotations for millions of additional variants
  • Links to actionable therapy options supported by local drug approval agencies, clinical studies and medical guidelines

Get the white paper

Screen capture of NAVIFY® Mutation Profiler for NGS clinical interpretation

Making NGS clinical interpretation simpler

navify Mutation Profiler helps reduce curation time and automates report generation, allowing you to support more gene panels, cancers and mutations with:

  • Pre-configured clinical and variant summaries that help reduce the time of interpretation
  • Annotations organized in a single, focused location

Easy to use

A clinical lab workflow based on lab clinician input, navify Mutation Profiler offers a clean, intuitive user interface and an outstanding user experience.

  • Lab and variant analytics with the option to opt-in for variant classification-sharing
  • Integrations with the laboratory information system and electronic medical record via APIs

Easily communicates potential personalized treatment strategies in a concise, professional report for oncologists

Explore
more

Partial image of white paper cover: Precision medicine requires precision in clinical interpretation and reporting with NAVIFY® Mutation Profiler

Precision medicine requires precision in clinical interpretation and reporting

Get the white paper

An image of clinicians engaged in advanced diagnostics through innovative technology

Driving a better future for patients

Read more

* navify Mutation Profiler is CE-IVD.  In the US, navify Mutation Profiler is Research Use Only (RUO). Not for use in diagnostic procedures or decisions.
¹ Campan et al. (2020). ‘Evaluation of Roche navify Mutation Profiler for NGS Variant Annotation and Reporting.’ Los Angeles: University of Southern California.

Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050

© 2023 Roche Molecular Systems, Inc.
NAVIFY is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.

Not all products of this product portfolio are intended or approved for diagnostic use. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

×

You will be redirected to another site. Do you want to continue?

OK